Case number 2017-1895
Reckitt Benckiser LLC v. Aurobindo Pharma Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | RECKITT BENCKISER LLC v. AUROBINDO PHARMA LTD. [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Oct 24, 2018 | 78 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [559913] [17-1895, 18-1131] [JAB] [Entered: 10/24/2018 10:14 AM] (1) |
| Oct 24, 2018 | 77 | ORDER filed denying [75] motion for sanctions against Reckitt-Benckiser LLC filed by Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [559910] [JAB] [Entered: 10/24/2018 10:12 AM] (2) |
| Oct 19, 2018 | 76 | RESPONSE of Appellant Reckitt Benckiser LLC to the motion [75] filed by Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 10/19/2018 by email. [558881] [17-1895] [Bella Satra] [Entered: 10/19/2018 05:10 PM] (26) |
| Oct 10, 2018 | 75 | MOTION of Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. for sanctions against Reckitt-Benckiser LLC [Consent: opposed]. Service: 10/10/2018 by email. [556217] [17-1895] [George Barry] [Entered: 10/10/2018 11:09 PM] (52) |
| Sep 10, 2018 | 74 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (FCR 36). (For the Court: Prost, Chief Judge; Moore, Circuit Judge and Reyna, Circuit Judge). [548340] [17-1895, 18-1131] [JAB] [Entered: 09/10/2018 10:28 AM] (5) |
| Sep 5, 2018 | 73 | Submitted after ORAL ARGUMENT by Mr. Douglas J. Nash for Reckitt Benckiser LLC and Mr. Timothy Kratz for Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd. Panel: Judge: Prost , Judge: Moore , Judge: Reyna. [547290] [JCP] [Entered: 09/05/2018 11:34 AM] (0) |
| Aug 14, 2018 | 72 | Response to oral argument order from the Appellant Reckitt Benckiser LLC. Designating Douglas J. Nash to argue.. Designating 12 minutes for argument. Reserving 3 minutes for rebuttal. [17-1895] [Bella Satra] [Entered: 08/14/2018 12:22 PM] (0) |
| Aug 14, 2018 | 71 | Response to oral argument order from the Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Designating Timothy H. Kratz to argue.. Designating 15 minutes for argument. [17-1895] [George Barry] [Entered: 08/14/2018 10:21 AM] (0) |
| Aug 7, 2018 | 70 | **TEXT ONLY** ORDER granting motion to withdraw attorney John T. Gutkoski [69] filed by Appellant Reckitt Benckiser LLC. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [541307] [JAB] [Entered: 08/07/2018 02:54 PM] (0) |
| Aug 7, 2018 | 69 | MOTION of Appellant Reckitt Benckiser LLC to withdraw counsel John Gutkoski [Consent: unopposed]. Service: 08/07/2018 by email. [541270] [17-1895] [Bella Satra] [Entered: 08/07/2018 01:52 PM] (9) |
| Aug 7, 2018 | 68 | Amended Entry of appearance for Douglas J. Nash as principal counsel for Appellant Reckitt Benckiser LLC. Service: 08/07/2018 by email. [541262] [17-1895] [Bella Satra] [Entered: 08/07/2018 01:37 PM] (2) |
| Jul 20, 2018 | 67 | NOTICE OF CALENDARING. Panel: 1809E. Case scheduled Sep 05, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to oral argument order due: 08/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [537287] [JAB] [Entered: 07/20/2018 12:06 PM] (0) |
| Apr 10, 2018 | 66 | 6 paper copies of the Confidential Joint Appendix in 5 Volumes [62] received from Appellant Reckitt Benckiser LLC. [512273] [JCP] [Entered: 04/11/2018 07:53 AM] (0) |
| Apr 10, 2018 | 65 | Notice from Appellant Reckitt Benckiser LLC regarding conflicts with oral argument (I respectfully request that the Court not schedule argument in this case on May 3-4. I am available to argue on all other days during the May sitting (April 30, May 1 or 2), June sitting (June 5-8) and July sitting (July 9-13).). Service: 04/10/2018 by email. [511988] [17-1895] [John Gutkoski] [Entered: 04/10/2018 10:20 AM] (1) |
| Apr 6, 2018 | 64 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 04/13/2018. [511312] [CAB] [Entered: 04/06/2018 01:08 PM] (0) |
| Apr 2, 2018 | 63 | JOINT APPENDIX, VOLS. I-V FILED for Reckitt Benckiser LLC, Aurobindo Pharma Ltd., and Aurobindo Pharma USA Inc. [58], [59]. Number of Pages: 2,045. Service: 04/02/2018 by email. [511167] [CAB] [Entered: 04/06/2018 10:12 AM] (2045) |
| Apr 2, 2018 | 62 | CONFIDENTIAL JOINT APPENDIX, VOLS. I - V FILED for Reckitt Benckiser LLC, Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. [56], [57]. Number of Pages: 2,573. Service: 04/02/2018 by US mail, email. The paper copies of the brief should be received by the court on or before 04/13/2018. [511159] --[Edited 04/06/2018 by CAB to correct date filed.] [CAB] [Entered: 04/06/2018 10:05 AM] (0) |
| Apr 2, 2018 | 61 | Joint Statement of Compliance with Fed. Cir. R. 33 for Cross-Appellants Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. and Appellant Reckitt Benckiser LLC. Service: 04/02/2018 by email. [509988] [17-1895] [John Gutkoski] [Entered: 04/02/2018 06:11 PM] (3) |
| Apr 2, 2018 | 60 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Reckitt Benckiser LLC. Service: 04/02/2018 by email. [509976] [17-1895] [John Gutkoski] [Entered: 04/02/2018 05:17 PM] (5) |
| Apr 2, 2018 | 59 | TENDERED from Cross-Appellants Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. and Appellant Reckitt Benckiser LLC. Title: JOINT APPENDIX. Service: 04/02/2018 by email. [509951] [17-1895] [John Gutkoski] [Entered: 04/02/2018 04:30 PM] (528) |
| Apr 2, 2018 | 58 | TENDERED from Cross-Appellants Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. and Appellant Reckitt Benckiser LLC. Title: JOINT APPENDIX. Service: 04/02/2018 by email. [509949] [17-1895] [John Gutkoski] [Entered: 04/02/2018 04:26 PM] (1517) |
| Apr 2, 2018 | 57 | TENDERED from Cross-Appellants Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. and Appellant Reckitt Benckiser LLC. Title: CONFIDENTIAL JOINT APPENDIX Service: 04/02/2018 by email. [509948] [17-1895] [John Gutkoski] [Entered: 04/02/2018 04:22 PM] (0) |
| Apr 2, 2018 | 56 | TENDERED from Cross-Appellants Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. and Appellant Reckitt Benckiser LLC. Title: CONFIDENTIAL JOINT APPENDIX Service: 04/02/2018 by email. [509944] [17-1895] [John Gutkoski] [Entered: 04/02/2018 04:18 PM] (0) |
| Mar 29, 2018 | 55 | 6 paper copies of the Reply Brief [54] received from Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. [509208] [SJL] [Entered: 03/29/2018 02:53 PM] (0) |
| Mar 26, 2018 | 54 | REPLY BRIEF FILED for Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. [53]. Number of Pages: 10. Service: 03/26/2018 by email. The paper copies of the brief should be received by the court on or before 04/03/2018. [508220] [CAB] [Entered: 03/27/2018 12:00 PM] (16) |
| Mar 26, 2018 | 53 | TENDERED from Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: REPLY BRIEF. Service: 03/26/2018 by email. [508040] [17-1895] [George Barry] [Entered: 03/26/2018 06:05 PM] (16) |
| Mar 15, 2018 | 52 | 6 paper copies of the Reply Brief [51] received from Appellant Reckitt Benckiser LLC. [505450] [JCP] [Entered: 03/15/2018 10:36 AM] (0) |
| Mar 12, 2018 | 51 | REPLY BRIEF FILED for Appellant Reckitt Benckiser LLC [50]. Number of Pages: 49. Service: 03/12/2018 by email. The paper copies of the brief should be received by the court on or before 03/21/2018. Cross-Appellant's reply brief is due 03/26/2018. [504459] [CAB] [Entered: 03/13/2018 09:08 AM] (59) |
| Mar 12, 2018 | 50 | TENDERED from Appellant Reckitt Benckiser LLC. Title: REPLY BRIEF. Service: 03/12/2018 by email. [504337] [John Gutkoski] [Entered: 03/12/2018 04:37 PM] (59) |
| Feb 7, 2018 | 49 | 6 paper copies of the Opening Response Brief [48] received from Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. [496140] [JCP] [Entered: 02/08/2018 10:17 AM] (0) |
| Jan 29, 2018 | 48 | BRIEF FILED for Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. [47]. Number of Pages: 56. Service: 01/29/2018 by email. The paper copies of the brief should be received by the court on or before 02/09/2018. [494806] [CAB] [Entered: 02/02/2018 01:23 PM] (70) |
| Jan 29, 2018 | 47 | TENDERED from Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Title: RESPONSE BRIEF. Service: 01/29/2018 by email. [493470] [George Barry] [Entered: 01/29/2018 04:24 PM] (70) |
| Jan 26, 2018 | 46 | 6 paper copies of the Corrected Confidential Opening Brief [44] received from Appellant Reckitt Benckiser LLC. [492981] [CFT] [Entered: 01/26/2018 10:39 AM] (0) |
| Jan 23, 2018 | 45 | CORRECTED BRIEF FILED for Appellant Reckitt Benckiser LLC [43]. Number of Pages: 57. Service: 01/23/2018 by email. [492668] [CAB] [Entered: 01/25/2018 11:30 AM] (264) |
| Jan 23, 2018 | 44 | CORRECTED CONFIDENTIAL BRIEF FILED for Appellant Reckitt Benckiser LLC [42]. Number of Pages: 57. Service: 01/23/2018 by US mail, email. The paper copies of the brief should be received by the court on or before 02/01/2018. [492666] [CAB] [Entered: 01/25/2018 11:24 AM] (0) |
| Jan 23, 2018 | 43 | TENDERED from Appellant Reckitt Benckiser LLC. Title: CORRECTED OPENING BRIEF. Service: 01/23/2018 by email. [491926] [John Gutkoski] [Entered: 01/23/2018 01:53 PM] (264) |
| Jan 23, 2018 | 42 | TENDERED from Appellant Reckitt Benckiser LLC. Title: CORRECTED CONFIDENTIAL OPENING BRIEF Service: 01/23/2018 by email. [491920] [John Gutkoski] [Entered: 01/23/2018 01:50 PM] (0) |
| Jan 19, 2018 | 40 | ORDER filed granting motion to waive confidentiality requirements [39] filed by Appellant Reckitt Benckiser LLC. Service: 01/19/2018 by clerk. [491040] [NL] [Entered: 01/19/2018 03:10 PM] (2) |
| Jan 19, 2018 | 41 | NOTICE OF REJECTION: The briefs of Appellant Reckitt Benckiser LLC, Non-confidential and Confidential Principal Brief for Plaintiff-Appellant [37], [38], are not in compliance with the rules of this court and is therefore rejected for filing (see Notice for further details). Corrected briefs are due 02/02/2018. Service as of this date by Clerk of Court. [491105] [CAB] [Entered: 01/19/2018 04:24 PM] (2) |
| Dec 20, 2017 | 39 | MOTION of Appellant Reckitt Benckiser LLC to waive confidentiality requirements. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/20/2017 by email. [484528] [John Gutkoski] [Entered: 12/20/2017 06:31 PM] (34) |
| Dec 20, 2017 | 38 | TENDERED from Appellant Reckitt Benckiser LLC. Title: CONFIDENTIAL OPENING BRIEF Service: 12/20/2017 by email. [484523] This brief has been rejected. See Doc No. [41] [John Gutkoski] [Entered: 12/20/2017 06:21 PM] (0) |
| Dec 20, 2017 | 37 | TENDERED from Appellant Reckitt Benckiser LLC. Title: OPENING BRIEF. Service: 12/20/2017 by email. [484522] This brief has been rejected. See Doc No. [41] [John Gutkoski] [Entered: 12/20/2017 06:18 PM] (0) |
| Dec 19, 2017 | 36 | Entry of appearance for Laura A. Vogel as of counsel for Appellant Reckitt Benckiser LLC. Service: 12/19/2017 by email. [483796] [Laura Vogel] [Entered: 12/19/2017 01:53 PM] (2) |
| Dec 1, 2017 | 35 | Note to file: 17-1895 (COMP COMPANION started 12/01/2017) with 17-2595. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [479552] [17-2595, 17-1895] [JB] [Entered: 12/01/2017 10:58 AM] (0) |
| Nov 15, 2017 | 34 | Docketing Statement for the Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 11/15/2017 by email. [475968] [George Barry] [Entered: 11/15/2017 05:41 PM] (5) |
| Nov 15, 2017 | 33 | Amended Certificate of Interest for the Cross-Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 11/15/2017 by email. [475965] [George Barry] [Entered: 11/15/2017 05:40 PM] (3) |
| Nov 15, 2017 | 32 | Entry of appearance for Bella S. Satra as of counsel for Appellant Reckitt Benckiser LLC. Service: 11/15/2017 by email. [475625] [Bella Satra] [Entered: 11/15/2017 09:31 AM] (2) |
| Nov 15, 2017 | 31 | Docketing Statement for the Appellant Reckitt Benckiser LLC. Service: 11/15/2017 by email. [475621] [John Gutkoski] [Entered: 11/15/2017 09:23 AM] (5) |
| Nov 15, 2017 | 30 | Certificate of Interest for the Appellant Reckitt Benckiser LLC. Service: 11/15/2017 by email. [475620] [John Gutkoski] [Entered: 11/15/2017 09:22 AM] (4) |
| Nov 3, 2017 | 29 | Note to file: The following cases are associated:17-1895 Lead with 18-1131 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [473018] [17-1895, 18-1131] [CAB] [Entered: 11/03/2017 02:39 PM] (0) |
| Nov 3, 2017 | 28 | ORDER lifting stay in 17-1895; consolidating appeals 17-1895 and 18-1131; setting briefing schedule in 17-1895 (see Order for further details); modifying the official caption in 17-1895 to reflect consolidation. Service as of this date by Clerk of Court. [473015] [17-1895, 18-1131] [CAB] [Entered: 11/03/2017 02:36 PM] (2) |
| Oct 31, 2017 | 27 | Letter from Appellant Reckitt Benckiser LLC Joint Letter re: Status of the Case and Proposed Schedule. Service: 10/31/2017 by email. [471908] [John Gutkoski] [Entered: 10/31/2017 12:56 PM] (2) |
| Oct 19, 2017 | 26 | Amended Entry of appearance for Timothy H. Kratz as principal counsel for Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 10/19/2017 by email. [469138] [George Barry] [Entered: 10/19/2017 01:16 PM] (2) |
| Oct 19, 2017 | 25 | Amended Entry of appearance for George J. Barry III as of counsel for Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 10/19/2017 by email. [469137] [George Barry] [Entered: 10/19/2017 01:15 PM] (2) |
| Oct 19, 2017 | 24 | NOTICE OF DEFICIENCY: The party letter Document Nos. [21] and [22] filed by Appellees Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd. in 17-1895 were submitted using the incorrect event and therefore cannot be accepted for filing at this time. [CLERK'S NOTE: The proper event is "Entry of Appearance Filed," which is under the "Forms and Certificates" event category. Then select "amended" on the drop down menu when prompted.] You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [469041] [CAB] [Entered: 10/19/2017 09:12 AM] (0) |
| Oct 18, 2017 | 23 | Amended Certificate of Interest for the Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 10/18/2017 by email. [468994] [George Barry] [Entered: 10/18/2017 07:19 PM] (3) |
| Oct 18, 2017 | 22 | Notice from Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. Entry of Appearance of Timothy H. Kratz. Service: 10/18/2017 by email. [468993] [George Barry] [Entered: 10/18/2017 07:17 PM] (0) |
| Oct 18, 2017 | 21 | Notice from Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. Entry of Appearance of George J. Barry III. Service: 10/18/2017 by email. [468992] [George Barry] [Entered: 10/18/2017 07:16 PM] (0) |
| Oct 6, 2017 | 20 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:party letters, Docket Nos. [16] and [18], ERROR: Amended Entries of Appearance for Attorneys George Barry, III and Timothy Kratz were not filed concurrently with Notice of Change of Law Firm Affiliation and Contact Information. CORRECTION: Attorneys Barry and Kratz must file amended entries of appearance, and updated their CM/ECF filer accounts. [466094] [CAB] [Entered: 10/06/2017 12:28 PM] (0) |
| Oct 6, 2017 | 19 | Notice of Rejection to Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc., the following document(s) cannot be filed: [17] certificate of interest. Reasons - Document is incomplete and is not accompanied by a certificate of service. A completed certificate of Interest must be submitted in accordance with Fed. Cir. R. 47.4 by 10/20/2017. [466091] [CAB] [Entered: 10/06/2017 12:13 PM] (1) |
| Oct 5, 2017 | 18 | Notice from Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. Change of Affiliation and Contact Information for Counsel of Record Timothy H. Kratz and George J. Barry III. Service: 10/05/2017 by email. [465892] [George Barry] [Entered: 10/05/2017 02:53 PM] (3) |
| Oct 5, 2017 | 17 | Amended Certificate of Interest for the Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 10/05/2017 by email. [465887] [George Barry] [Entered: 10/05/2017 02:51 PM] (0) |
| Oct 5, 2017 | 16 | Notice from Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. Change of Law Firm Affiliation of Counsel of Record Timothy H. Kratz and George J. Barry III. Service: 10/05/2017 by email. [465867] [George Barry] [Entered: 10/05/2017 02:24 PM] (3) |
| Sep 29, 2017 | 15 | **TEXT ONLY** ORDER granting motion to withdraw Meghan M. Rachford as counsel [14] filed by Appellees Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [464245] [CAB] [Entered: 09/29/2017 08:56 AM] (0) |
| Sep 28, 2017 | 14 | MOTION of Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. to withdraw counsel Meghan M. Rachford. Any response is due within 10 days of service [Consent: unopposed]. Service: 09/28/2017 by email. [464183] [Meghan Rachford] [Entered: 09/28/2017 04:34 PM] (4) |
| May 1, 2017 | 13 | ORDER filed. The motion [5] is granted to the extent that the briefing schedule is stayed. The parties are directed to inform the court within 15 days of the district court's ruling on Appellees' motion for attorney fees as to how this appeal should proceed. Service: 05/01/2017 by clerk. [428177] [LMS] [Entered: 05/01/2017 12:07 PM] (2) |
| Apr 26, 2017 | 12 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [11], ERROR: The firm name and contact information on your Entry of Appearance (Douglas J. Nash) does not match what we have in our database. CORRECTION: Update your firm name and contact information with the PACER service center. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [427392] [JCA] [Entered: 04/26/2017 04:50 PM] (0) |
| Apr 26, 2017 | 11 | Entry of appearance for Douglas J. Nash as of counsel for Appellant Reckitt Benckiser LLC. Service: 04/26/2017 by email. [427385] [Douglas Nash] [Entered: 04/26/2017 04:44 PM] (2) |
| Apr 26, 2017 | 10 | Docketing Statement for the Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 04/26/2017 by email. [427184] [Meghan Rachford] [Entered: 04/26/2017 10:22 AM] (4) |
| Apr 26, 2017 | 9 | Certificate of Interest for the Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 04/26/2017 by email. [427183] [Meghan Rachford] [Entered: 04/26/2017 10:20 AM] (2) |
| Apr 26, 2017 | 8 | Entry of appearance for Meghan M. Rachford as of counsel for Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 04/26/2017 by email. [427181] [Meghan Rachford] [Entered: 04/26/2017 10:18 AM] (2) |
| Apr 26, 2017 | 7 | Entry of appearance for George J. Barry III as of counsel for Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 04/26/2017 by email. [427177] [George Barry] [Entered: 04/26/2017 10:12 AM] (2) |
| Apr 26, 2017 | 6 | Entry of appearance for Timothy H. Kratz as principal counsel for Appellees Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.. Service: 04/26/2017 by email. [427175] [Timothy Kratz] [Entered: 04/26/2017 10:08 AM] (2) |
| Apr 24, 2017 | 5 | MOTION of Appellant Reckitt Benckiser LLC to stay appeal. Any response is due within 10 days of service [Consent: unopposed]. Service: 04/24/2017 by US mail, email. [426619] [John Gutkoski] [Entered: 04/24/2017 02:48 PM] (10) |
| Apr 24, 2017 | 4 | Docketing Statement for the Appellant Reckitt Benckiser LLC. Service: 04/24/2017 by US mail, email. [426604] [John Gutkoski] [Entered: 04/24/2017 02:15 PM] (5) |
| Apr 24, 2017 | 3 | Certificate of Interest for the Appellant Reckitt Benckiser LLC. Service: 04/24/2017 by US mail, email. [426599] [John Gutkoski] [Entered: 04/24/2017 02:11 PM] (3) |
| Apr 24, 2017 | 2 | Entry of appearance for John T. Gutkoski as principal counsel for Appellant Reckitt Benckiser LLC. Service: 04/24/2017 by US mail, email. [426594] [John Gutkoski] [Entered: 04/24/2017 02:07 PM] (2) |
| Apr 12, 2017 | 1 | Appeal docketed. Received: 04/11/2017. [423369]Entry of Appearance due 04/26/2017. Certificate of Interest is due on 04/26/2017. Docketing Statement due 04/26/2017. Appellant/Petitioner's brief is due 06/12/2017. [JCA] [Entered: 04/12/2017 11:01 AM] (30) |
